Announcements Trials
Browse Landscape

Status

Completed 3Unknown 2Active not recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1INDUSTRY 1

Study Type

Observational 3

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1

Conditions

Neoplasms 2COVID-19 2Lung Neoplasms 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × COVID-19 Vaccines × Clear all
NCT04784689 2023-05-25

Host Immune Response to Novel RNA COVID-19 Vaccination

The University of Texas Health Science Center at San Antonio

Completed
50 enrolled
Tumor-Agnostic

Neoplasms

NCT04910295 2023-04-12

Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients

Seoul National University Hospital

Completed
112 enrolled

COVID-19, Neoplasms

NCT05009030 2022-07-29

VAC-CaP

Fundación GECP

Completed
794 enrolled
Thoracic

COVID-19, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡